Re:Apple Patent on Touch Typing, Multitouch Upheld; Allows B...
by marcosdumay on Monday October 21, 2013 @12:31PM
(#6586583)
There are two main issues with that argument (they don't completely invalidate the argument, but you should be aware of them):
1 - Most of that R&D cost is created because companies must create small differences between their products, requiring new tests. That is, if patents were absent, the society would need to spend a much smaller sum for the same gain.
2 - The pharmaceutical industry isn't an unbiased party of that research (quite obviously) and thus it isn't the ideal party for administrating it.
But, like I said, it does not invalidate the argument. Those issues also don't have an obvious solution (as far as I can see), but they exist.
1 - Most of that R&D cost is created because companies must create small differences between their products, requiring new tests. That is, if patents were absent, the society would need to spend a much smaller sum for the same gain.
2 - The pharmaceutical industry isn't an unbiased party of that research (quite obviously) and thus it isn't the ideal party for administrating it.
But, like I said, it does not invalidate the argument. Those issues also don't have an obvious solution (as far as I can see), but they exist.